Meridian Medical Technologies Invests US$100 million to Expand Manufacuring Facilities
Introduction:
Meridian Medical Technologies plans to expand manufacturing capabilities in Missouri, USA.
Features:
The construction of the new 155,000-square-foot facility is aimed at bolstering the production of drug-device combination products or enhancing sterile fill-finish capabilities.
The investment in the facility is expected to play a crucial role in supporting these enhanced capabilities on a global scale.
The facility's primary purpose is to facilitate the development and manufacturing of new medicines, thereby enabling access customers globally.
This investment not only brings economic benefits but also highlights the commitment to innovation and progress within the healthcare industry. By expanding its infrastructure also brings additional job opportunities and enhance production capacities.
The new facility is projected to be finished by 2024.
Specifications:
Name Meridian Medical Technologies
Type New Construction
Budget US$100 million
Year 2024
